Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 1
2004 2
2006 3
2008 6
2009 1
2012 1
2013 1
2014 3
2015 1
2016 2
2017 3
2018 1
2019 2
2020 1
2021 3
2022 2
2023 3
2024 3
2025 5
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

41 results

Results by year

Filters applied: . Clear all
Page 1
CD40 agonist mitazalimab with mFOLFIRINOX in untreated metastatic pancreatic cancer: Biomarkers associated with outcomes from OPTIMIZE-1.
Van Laethem JL, Geboes K, Borbath I, Macarulla Mercade T, Lambert A, Cassier P, Prenen H, Mitry E, Blanc JF, Pilla L, Feliu J, Rodriguez Garrote M, Pazo-Cid RA, Gallego I, Smith KE, Nordbladh K, Jimenez DG, Ellmark P, Pico de Coaña Y, Ambarkhane SV, Beatty GL, O'Reilly EM. Van Laethem JL, et al. Among authors: ellmark p. Cell Rep Med. 2025 Oct 21;6(10):102407. doi: 10.1016/j.xcrm.2025.102407. Epub 2025 Oct 7. Cell Rep Med. 2025. PMID: 41061701 Free PMC article. Clinical Trial.
Next-generation CD40 agonists for cancer immunotherapy.
Andersson H, Nyesiga B, Hermodsson T, Enell Smith K, Hägerbrand K, Lindstedt M, Ellmark P. Andersson H, et al. Among authors: ellmark p. Expert Opin Biol Ther. 2024 May;24(5):351-363. doi: 10.1080/14712598.2024.2357714. Epub 2024 May 23. Expert Opin Biol Ther. 2024. PMID: 38764393 Free article. Review.
REACtiVe-2: phase I evaluation of dendritic cell vaccination and agonistic CD40 therapy following (m)FOLFIRINOX in metastatic pancreatic cancer.
Kucukcelebi S, van 't Land FR, van der Burg SH, Eskens FALM, Homs MYV, Willemsen M, Onrust-van Schoonhoven A, Rozendaal NEM, Fellah A, Vadgama D, Moskie M, Bezemer K, Doukas M, van Eijck CWF, Stadhouders R, de Vos-Geelen J, van Diepen AE, Enninga I, Meijer R, Ambarkhane SV, Ellmark P, Aerts JGJV, Groeneveldt C, van Eijck CHJ. Kucukcelebi S, et al. Among authors: ellmark p. Nat Commun. 2025 Nov 28;16(1):10609. doi: 10.1038/s41467-025-66092-1. Nat Commun. 2025. PMID: 41315287 Free PMC article. Clinical Trial.
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1): a single-arm, multicentre phase 1b/2 study.
Van Laethem JL, Borbath I, Prenen H, Geboes KP, Lambert A, Mitry E, Cassier PA, Blanc JF, Pilla L, Batlle JF, Garrote MR, Pazo-Cid RA, Gallego I, Smith KE, Ellmark P, Pico de Coaña Y, Ambarkhane SV, Macarulla T. Van Laethem JL, et al. Among authors: ellmark p. Lancet Oncol. 2024 Jul;25(7):853-864. doi: 10.1016/S1470-2045(24)00263-8. Epub 2024 Jun 1. Lancet Oncol. 2024. PMID: 38834087 Clinical Trial.
ATOR-4066, a Bispecific Antibody Targeting CD40 and CEACAM5, Induces Strong Myeloid and T Cell-Dependent Tumor Immunity and Synergizes with PD-1 Blockade.
Andersson H, Uddbäck I, Hermodsson T, Celander M, Krishna Shetty A, Ljung L, Nilsson A, Sundstedt A, von Schantz L, Varas LA, Levin M, Säll A, Weilguny D, Jansson K, Fritzell S, Hägerbrand K, Lindstedt M, Ellmark P. Andersson H, et al. Among authors: ellmark p. Cancer Immunol Res. 2025 Dec 2;13(12):1987-2003. doi: 10.1158/2326-6066.CIR-25-0075. Cancer Immunol Res. 2025. PMID: 40928366 Free PMC article.
Distinct Infiltration of T Cell Populations in Bladder Cancer Molecular Subtypes.
Sincic V, Arlenhold KF, Richtmann S, Lilljebjörn H, Eriksson P, Sjödahl G, Wokander M, Hägerbrand K, Ellmark P, Fioretos T, Borrebaeck CAK, Liedberg F, Lundberg K. Sincic V, et al. Among authors: ellmark p. Cells. 2024 May 28;13(11):926. doi: 10.3390/cells13110926. Cells. 2024. PMID: 38891058 Free PMC article.
41 results